“Miach Orthopaedics is proud to partner with Endeavour Vision and is thrilled with the team’s positive impact on our organization. Right from the start of their Series B due diligence, Endeavour proved a value-added investor. Their thorough preparation, understanding of our sports medicine business, and shared insights into early commercialization challenges enhanced our business plan. Post-investment, Endeavour’s keen sense of strategy and tactics has facilitated our successful commercial introduction.”

Patrick A. McBrayer, President & CEO, Miach Orthopaedics

“From our introductory meeting, through the diligence and investment process and now as an active board member, the Endeavour Vision team has been a great partner. The team brings deep insights and a pragmatic approach to assisting high growth companies across a broad array of disciplines. Moreover, the team is a pleasure to work with and we look forward to our great partnership with Endeavour Vision as we continue to grow globally.”

Robert Spignesi, CEO, Rapid Micro Biosystems

“We are delighted to have Endeavour Vision as our partner on Willow’s mission of building solutions to moms’ most meaningful problems. They bring deep passion for our work; robust and relevant industry insights; excellent connections; and they ask outstanding, perceptive questions that help us ensure we’re thinking about and tackling the most important topics.”

Laura Chambers, CEO, Willow

“As the founding investor in CeQur, Endeavour Vision has been an invaluable partner over the years, providing strategic input, on-going support and financing. I’ve enjoyed getting to know several members of the team, each bringing their own unique expertise, and all committed to our success. In the world of healthcare technology investors, you’d be hard pressed to find a better partner.”

Bradley Paddock, CEO, CeQur Corporation

“Endeavour Vision has been a dedicated and trusted partner in our journey to transform the diagnosis and treatment of vertebrogenic pain. The Endeavor Vision team has provided meaningful strategic insights as we evolved from our initial market launch, securing our CPT I code and full commercialization. We look forward to EV’s continued partnership and contributions as we accelerate our commercial efforts and prepare for the public market.”

Tyler Binney, CEO, Relievant

“We find in Endeavour Vision a unique and highly-sophisticated team, which adds significant value to our commercialization ramp-up. This includes strategic input, organisational development and talent acquisition. They’re an investment team which works closely with management to identify creative solutions to complex issues, leading the maximum value creation for the enterprise. I highly recommend Endeavour Vision as a valuable venture partner.”

Earl R. Fender, Previously President & CEO, Vertiflex

“Endeavour Vision is a trusted and highly effective global thought partner who believes in building a company the right way. Operationally the Endeavour Vision team has broad skill sets including product development, regulatory science, clinical execution, and product launches to help achieve our mutual vision of providing a safe and effective transformational therapy that becomes the standard of care for patients worldwide.”

Dennis Wahr, CEO, Nuvaira

“Endeavour Vision is an extremely thorough and thoughtful healthcare investor, and at Virtual Incision we sincerely value and appreciate their Series C support. EV brings domain knowledge and a global perspective to help us pioneer the use of mini-robots for abdominal procedures — great partners to have around our board table.”

John Murphy, CEO, Virtual Incision Corporation

“Endeavour Vision’s team brought an in-depth knowledge of our field – highlighted by impressive and thorough 360˚ due diligence, the long-term perspective required to build substantial companies, outstanding experience of bringing venture to financial success and an uncommon sense for team work. This is “smart money” at its best.”

Jaques R. Essinger, former CEO, Symetis

“Endeavour Vision became our preferred partner to enter our next growth stage for a multitude of reasons. Aside from the deep level of expertise in HealthTech overall and their long-term perspective on creating sustainable change in the sector, we really valued the strong involvement of senior experts from the get go. As a result, the due diligence questions were sharp, challenging and to the point, which allowed us to dive into deep strategic conversations fast. Lastly, we simply clicked with the great team on a professional and personal level, who share the same passion to re-invent a much needed space.”

Katrin Alberding and Clemens Raemy, Co-CEOs, Kenbi